Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3073% above fair value
$61.72−0.25 (-0.40%)
Close on Nov 13, 2026Market cap $2.12BP/E 36.3Yield –
Ingevity EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Ingevity's EV/EBITDA was 23.7× on Nov 11, 2026, against 5.7× a year earlier. Over the last 5 years it ranged from 4.7× to 41.8×, with a median of 6.7×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.7× | −12.7 |
| 2025 | Dec 31, 2025 | 36.4× | +30.6 |
| 2024 | Dec 31, 2024 | 5.8× | −0.0 |
| 2023 | Dec 29, 2023 | 5.8× | −0.7 |
| 2022 | Dec 30, 2022 | 6.6× | −0.2 |
| 2021 | Dec 31, 2021 | 6.8× | −2.1 |
| 2020 | Dec 31, 2020 | 8.9× | −1.9 |
| 2019 | Dec 31, 2019 | 10.8× | −0.3 |
| 2018 | Dec 31, 2018 | 11.0× | −3.9 |
| 2017 | Dec 29, 2017 | 14.9× | +0.6 |
| 2016 | Dec 30, 2016 | 14.3× | – |
See a number that looks wrong?